Last reviewed · How we verify
NCT06142877
Effects of Social Media Use on Young Adults' E-Cigarette Use
NA trial testing Social Media Use Reduction in Electronic Cigarette Use in 200 participants. Currently enrolling.
1 February 2025
Quick facts
| Lead sponsor | University of Oklahoma |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 4 December 2023 |
| Primary completion | 1 February 2025 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Social Media Use Reduction
Conditions studied
- Electronic Cigarette Use — all drugs for Electronic Cigarette Use →
Sponsor
University of Oklahoma
Who can join
Adults 18 to 25, any sex, with Electronic Cigarette Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to test the effects of social media use on e-cigarette use in young adults who use e-cigarettes. The main questions it aims to answer are: * Does reducing social media use change young adults' e-cigarette use? * Does reducing social media use change things such as young adults' mental health and what they see on social media? Participants will complete surveys and submit screenshots showing how much time they spend on social media. Researchers will compare young adults who reduce their social media use to young adults who use social media as usual, to see if their e-cigarette use differs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06142877
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Electronic Cigarette Use
Currently open trials in the same condition.
- NCT06609109 — Effect of Cannabis on E-Cigarette Use Behavior · Phase 1 · recruiting
- NCT06610838 — Effects of E-cigarette Use on Health · recruiting
- NCT04907136 — Developing and Testing Health Warning Labels on the ENDS Device · NA · recruiting
- NCT05338801 — Effect of Menthol on ENDS Users' Addiction and Exposure · NA · recruiting
- NCT05396911 — Development of UP2UTobacco for High School Youth · NA · active not recruiting
Other University of Oklahoma trials
Trials by the same sponsor.
- NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
- NCT07494773 — Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection · Phase 1, PHASE2 · not yet recruiting
- NCT07014605 — Smoking Cessation Program for Lao People With HIV · NA · not yet recruiting
- NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
- NCT07491653 — Fiber mHealth Intervention for Prediabetes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06142877 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oklahoma
- Last refreshed: 7 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06142877.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing